Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIDDK

Inverse Agonists for the TSH Receptor

  • Read more about Inverse Agonists for the TSH Receptor
US Application 61/322,138
Filed on 2010-04-08

Programmable Self-Assembled Nanostructures Based On Sidechain-Modified PNAfor The Multivalent Display Of Ligands`

  • Read more about Programmable Self-Assembled Nanostructures Based On Sidechain-Modified PNAfor The Multivalent Display Of Ligands`
US Application 61/333,442
Filed on 2010-05-11

Nicotinic Acetylcholine Receptor Agonists

  • Read more about Nicotinic Acetylcholine Receptor Agonists
US Application 61/315,674
Filed on 2010-03-19

Natural Product Inhibitors Of Drug-susceptible And Drug-resistant Bacteria And The Bacterial Cytoskeletal Protein FtsZ

  • Read more about Natural Product Inhibitors Of Drug-susceptible And Drug-resistant Bacteria And The Bacterial Cytoskeletal Protein FtsZ
US Application 61/308,911
Filed on 2010-02-27

Genotype 1b Hepatitis C Virus Cell Culture System.

  • Read more about Genotype 1b Hepatitis C Virus Cell Culture System.
US Application 61/248,229
Filed on 2009-10-02

(N)-Methanocarba Adenosine Derivatives And Their Dendrimer Conjugates As A3 Receptor Agonists

  • Read more about (N)-Methanocarba Adenosine Derivatives And Their Dendrimer Conjugates As A3 Receptor Agonists
US Application 61/313,961
Filed on 2010-03-15

(N)-Methanocarba Adenosine Derivatives And Their Dendrimer Conjugates As A3 Receptor Agonists

  • Read more about (N)-Methanocarba Adenosine Derivatives And Their Dendrimer Conjugates As A3 Receptor Agonists
US Application 61/266,084
Filed on 2009-12-02

Protection From Obesity And Diabetes By Blockade Of TGF-beta/Smad3 Signaling

  • Read more about Protection From Obesity And Diabetes By Blockade Of TGF-beta/Smad3 Signaling
US Application 61/254,629
Filed on 2009-10-23

Genome-Wide Discovery Of Host Factors Required For Productive HCV Infection

  • Read more about Genome-Wide Discovery Of Host Factors Required For Productive HCV Infection
US Application 61/222,833
Filed on 2009-07-02

STAMP Affects The Growth Of Transformed And Ovarian Cancer Cell

  • Read more about STAMP Affects The Growth Of Transformed And Ovarian Cancer Cell
US Application 61/185,503
Filed on 2009-06-09

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIDDK
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health